M. Redecha, m. Papcun, m. Foltín, m. Suchánek, p. Papcun, m. Križko, M. Gábor, v. Ferianec, k. Holomáň
Uterine sarcomas are rare tumours of the uterus with poor prognosis due to their
aggressiveness. They account for about 1 % of all gynaecologic malignancies and
3-7% of all uterine cancer with an incidence of 0.4/100,000 women. Their relatively
low incidence and wide histopathological diversity result in inconclusive determination
of the survival risk factors, disease progression, and in the parameters for optimal
treatment. The disease is often diagnosed at higher stages with poor survival
prognosis. For the diagnosis and consequent follow-up of the disease, clear ultrasonography
parameters or other biomarkers have not been clearly set. The treatment
of the disease consists of surgical treatment if possible, followed by subsequent radiotherapy
or chemotherapy for certain types of sarcomas. Better knowledge of the
pathophysiology of these tumour could improve the diagnosis and subsequent treatment
of the disease. Authors in the paper present their six-year experience in the
diagnosis and treatment of uterine sarcomas.